CorMedix Inc.

Pharmaceutical company · Parsippany, New Jersey, United States · Nasdaq: CRMD

CorMedix Inc. is a pharmaceutical company headquartered in Parsippany, New Jersey, United States. Its earliest recorded incorporation is in 2006. Its shares trade on Nasdaq under the ticker CRMD. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $281,494 in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $850,000 sold in a notice filed in 2012.

www.cormedix.comProfile compiled from public records. Is this your company? Request a correction or update

CorMedix at a glance

Typepharmaceutical company
HeadquartersParsippany, New Jersey, United States
Earliest incorporation on record2006
Stock listingNasdaq: CRMD
SEC industryPharmaceutical Preparations
Employees (per SBIR records)10
SEC CIK1410098

What does CorMedix do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $281,494 in total (2017). NIH funding came from the National Institute of General Medical Sciences.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $850,000 sold (2012).

Frequently asked questions about CorMedix

Where is CorMedix headquartered?

CorMedix Inc. is headquartered in Parsippany, New Jersey, United States.

What does CorMedix do?

CorMedix Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is CorMedix a public company?

Yes. CorMedix Inc. trades on Nasdaq under the ticker CRMD.

When was CorMedix founded?

The earliest incorporation on record for CorMedix Inc. is in 2006, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.